Solid Biosciences Inc (SLDB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||
| Net Income | -13,875 | -23,770 | -6,660 |
| Depreciation Amortization | 158 | 560 | 5 |
| Accounts payable and accrued liabilities | 832 | N/A | N/A |
| Other Working Capital | 291 | 2,780 | 1,580 |
| Other Operating Activity | 2,398 | 310 | 875 |
| Operating Cash Flow | $-10,196 | $-20,120 | $-4,200 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | 7,210 | N/A | N/A |
| PPE Investments | -248 | -390 | 0 |
| Other Investing Activity | 0 | -3,820 | -26,800 |
| Investing Cash Flow | $6,962 | $-4,210 | $-26,800 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 24,822 | 3,420 | 51,590 |
| Financing Cash Flow | $24,822 | $3,420 | $51,590 |
| Beginning Cash Position | 7,843 | 28,590 | 8,010 |
| End Cash Position | 29,431 | 7,670 | 28,590 |
| Net Cash Flow | $21,588 | $-20,910 | $20,580 |
| Free Cash Flow | |||
| Operating Cash Flow | -10,196 | -20,120 | -4,200 |
| Capital Expenditure | -248 | N/A | N/A |
| Free Cash Flow | -10,444 | -20,120 | -4,200 |